These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9029757)

  • 41. Resolution of ofloxacin-ciprofloxacin and ofloxacin-norfloxacin binary mixtures by flow-injection chemiluminescence in combination with partial least squares multivariate calibration.
    Murillo JA; Alañón Molina A; Muñoz de la Peña A; Durán Merás I; Jiménez Girón A
    J Fluoresc; 2007 Sep; 17(5):481-91. PubMed ID: 17577647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experience with a urine opiate screening and confirmation cutoff of 2000 ng/mL.
    Fraser AD; Worth D
    J Anal Toxicol; 1999 Oct; 23(6):549-51. PubMed ID: 10517566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the usefulness of an oxycodone immunoassay in combination with a traditional opiate immunoassay for the screening of opiates in urine.
    Gingras M; Laberge MH; Lefebvre M
    J Anal Toxicol; 2010 Mar; 34(2):78-83. PubMed ID: 20223099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An evaluation of the OnTrak Testcup-er on-site urine drug-testing device for drugs commonly encountered from emergency departments.
    Peace MR; Poklis JL; Tarnai LD; Poklis A
    J Anal Toxicol; 2002 Oct; 26(7):500-3. PubMed ID: 12423007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urinary excretion and bactericidal activities of gemifloxacin and ofloxacin after a single oral dose in healthy volunteers.
    Naber CK; Hammer M; Kinzig-Schippers M; Sauber C; Sörgel F; Bygate EA; Fairless AJ; Machka K; Naber KG
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3524-30. PubMed ID: 11709334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemiluminescence determination of fluoroquinolones using Fenton system in the presence of terbium(iii) ions.
    Kaczmarek M; Lis S
    Analyst; 2011 Jun; 136(12):2592-7. PubMed ID: 21519592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
    Wiegand RF; Klette KL; Stout PR; Gehlhausen JM
    J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Limitations of EMIT benzodiazepine immunoassay for monitoring compliance of patients with benzodiazepine therapy even after hydrolyzing glucuronide metabolites in urine to increase cross-reactivity: comparison of immunoassay results with LC-MS/MS values.
    Dixon RB; Floyd D; Dasgupta A
    Ther Drug Monit; 2015 Feb; 37(1):137-9. PubMed ID: 25004136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of ofloxacin, norfloxacin, nalidixic acid, pyromidic acid and pipemidic acid on human gamma-interferon production and blastogenesis.
    De Simone C; Baldinelli L; Ferrazzi M; De Santis S; Pugnaloni L; Sorice F
    J Antimicrob Chemother; 1986 Jun; 17(6):811-4. PubMed ID: 3090010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Commonly used fluoroquinolones cross-react with urine drug screens for opiates, buprenorphine, and amphetamines.
    Colby JM; Patel PC; Fu DY; Rutherford NJ
    Clin Biochem; 2019 Jun; 68():50-54. PubMed ID: 30991036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin.
    Syrjälä H; Schildt R; Räisäinen S
    Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):68-70. PubMed ID: 1864276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Susceptibility to quinolones of Salmonella isolated from men and animals].
    Avril JL; Couete I; Travert MF; Autuly F; Plessis P
    Pathol Biol (Paris); 1995 Apr; 43(4):270-3. PubMed ID: 7567113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer.
    Kamat AM; DeHaven JI; Lamm DL
    Urology; 1999 Jul; 54(1):56-61. PubMed ID: 10414727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samples.
    Holler JM; Bosy TZ; Klette KL; Wiegand R; Jemionek J; Jacobs A
    J Anal Toxicol; 2004 Sep; 28(6):489-93. PubMed ID: 15516301
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography.
    Boppana VK; Swanson BN
    Antimicrob Agents Chemother; 1982 May; 21(5):808-10. PubMed ID: 6213199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA; Tayeb OS
    Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration.
    Diamond JP; White L; Leeming JP; Bing Hoh H; Easty DL
    Br J Ophthalmol; 1995 Jun; 79(6):606-9. PubMed ID: 7626579
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the Triage PPY on-site testing device for the detection of dextropropoxyphene in urine.
    Poklis A; Poklis JL; Tarnai LD; Backer RC
    J Anal Toxicol; 2004 Sep; 28(6):485-8. PubMed ID: 15516300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.